EPathOptimize: A combinatorial approach for transcriptional balancing of metabolic pathways

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Jones, J Andrew ^a   Vernacchio, Victoria R ^a   Lachance, Daniel M ^b   Lebovich, Matthew ^a   Fu, Li ^b   Shirke, Abhijit N ^b   Schultz, Victor L ^b   Cress, Brady ^a   Linhardt, Robert J ^a,b   Koffas, Mattheos A G ^a,b  

^a RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^b Research Rensselaer Polytechnic Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; INDOLE DERIVATIVE; VIOLACEIN;

ENTEROBACTERIA PHAGE T7; ESCHERICHIA COLI; GENE LIBRARY; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PLASMID; PROMOTER REGION; PSEUDOALTEROMONAS; TRANSCRIPTION INITIATION;

BACTERIOPHAGE T7; DNA, BACTERIAL; ESCHERICHIA COLI; GENE LIBRARY; INDOLES; METABOLIC NETWORKS AND PATHWAYS; PLASMIDS; PROMOTER REGIONS, GENETIC; PSEUDOALTEROMONAS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 84931292024     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11301     Document Type: Article

References (37)

1. Steen, E. J. et al. Microbial production of fatty-acid-derived fuels and chemicals from plant biomass. Nature 463, 559-62 (2010).
2. Ajikumar, P. K. et al. Isoprenoid pathway optimization for Taxol precursor overproduction in Escherichia coli. Science 330, 70-4 (2010).
3. Lu, X., Vora, H. & Khosla, C. Overproduction of free fatty acids in E. coli: implications for biodiesel production. Metab. Eng. 10, 333-9 (2008).
4. Paddon, C. J. et al. High-level semi-synthetic production of the potent antimalarial artemisinin. Nature 496, 528-32 (2013).
5. Xu, P. et al. Modular optimization of multi-gene pathways for fatty acids production in E. coli. Nat. Commun. 4, 1409 (2013).
6. Thodey, K., Galanie, S. & Smolke, C. D. A microbial biomanufacturing platform for natural and semisynthetic opioids. Nat. Chem. Biol. 10, 837-844 (2014).
7. Kallio, P., Pásztor, A., Thiel, K., Akhtar, M. K. & Jones, P. R. An engineered pathway for the biosynthesis of renewable propane. Nat. Commun. 5, 4731 (2014).
8. Howard, T. P. et al. Synthesis of customized petroleum-replica fuel molecules by targeted modification of free fatty acid pools in Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 110, 7636-41 (2013).
9. Zhao, S. et al. Improvement of catechin production in Escherichia coli through combinatorial metabolic engineering. Metab. Eng. 28, 43-53 (2014).
10. He, W. et al. Production of chondroitin in metabolically engineered E. coli. Metab. Eng. 27, 92-100 (2015).
11. Blazeck, J., Garg, R., Reed, B. & Alper, H. S. Controlling promoter strength and regulation in Saccharomyces cerevisiae using synthetic hybrid promoters. Biotechnol. Bioeng. 109, 2884-95 (2012).
12. Anthony, J. R. et al. Optimization of the mevalonate-based isoprenoid biosynthetic pathway in Escherichia coli for production of the anti-malarial drug precursor amorpha-4, 11-diene. Metab. Eng. 11, 13-9 (2009).
13. Dueber, J. E. et al. Synthetic protein scaffolds provide modular control over metabolic flux. Nat. Biotechnol. 27, 753-9 (2009).
14. Xu, P., Li, L., Zhang, F., Stephanopoulos, G. & Koffas, M. Improving fatty acids production by engineering dynamic pathway regulation and metabolic control. Proc. Natl. Acad. Sci. 111, 11299-11304 (2014).
15. Jones, J. A., Toparlak, Ö. D. & Koffas, M. A. Metabolic pathway balancing and its role in the production of biofuels and chemicals. Curr. Opin. Biotechnol. 33, 52-59 (2015).
16. Mairhofer, J., Scharl, T., Marisch, K., Cserjan-Puschmann, M. & Striedner, G. Comparative transcription profiling and in-depth characterization of plasmid-based and plasmid-free Escherichia coli expression systems under production conditions. Appl. Environ. Microbiol. 79, 3802-12 (2013).
17. Mijakovic, I., Petranovic, D. & Jensen, P. R. Tunable promoters in systems biology. Curr. Opin. Biotechnol. 16, 329-35 (2005).
18. Mertens, N., Remaut, E. & Fiers, W. Tight transcriptional control mechanism ensures stable high-level expression from T7 promoter-based expression plasmids. Bio/Technology (1995).
19. Nakamura, Y., Asada, C. & Sawada, T. Production of antibacterial violet pigment by psychrotropic bacterium RT102 strain. Biotechnol. Bioprocess Eng. 8, 37-40 (2003).
20. Shirata, A. et al. Production of bluish-purple pigments by Janthinobacterium lividum isolated from the raw silk and dyeing with them. J. Sericultural Sci. Japan (1997).
21. Melo, P. da S., Maria, S. S., Vidal, B. de C., Haun, M. & Duran, N. Violacein cytotoxicity and induction of apoptosis in V79 cells. Vitr. Cell. Dev. Biol.-Anim. 36, 539 (2000).
22. Bromberg, N. et al. Growth inhibition and pro-apoptotic activity of violacein in Ehrlich ascites tumor. Chem. Biol. Interact. 186, 43-52 (2010).
23. Durán, M. et al. Potential applications of violacein: a microbial pigment. Med. Chem. Res. 21, 1524-1532 (2011).
24. Durán, N. et al. Violacein: properties and biological activities. Biotechnol. Appl. Biochem. 48, 127-33 (2007).
25. Durán, M., Faljoni-Alario, A. & Durán, N. Chromobacterium violaceum and its important metabolites-review. Folia Microbiol. (Praha). 55, 535-47 (2010).
26. Venil, C. K., Zakaria, Z. A. & Ahmad, W. A. Bacterial pigments and their applications. Process Biochem. 48, 1065-1079 (2013).
27. Rodriguez, A. et al. Engineering Escherichia coli to overproduce aromatic amino acids and derived compounds. Microb. Cell Fact. 13, 126 (2014).
28. Lee, M. E., Aswani, A., Han, A. S., Tomlin, C. J. & Dueber, J. E. Expression-level optimization of a multi-enzyme pathway in the absence of a high-throughput assay. Nucleic Acids Res. 41, 10668-78 (2013).
29. Xu, P., Vansiri, A., Bhan, N. & Koffas, M. A. G. ePathBrick: A Synthetic Biology Platform for Engineering Metabolic Pathways in E. coli. ACS Synth. Biol. 1, 256-66 (2012).
30. Rodrigues, A. L. et al. Systems metabolic engineering of Escherichia coli for production of the antitumor drugs violacein and deoxyviolacein. Metab. Eng. 20, 29-41 (2013).
31. Rodrigues, A. L., Becker, J., de Souza Lima, A. O., Porto, L. M. & Wittmann, C. Systems metabolic engineering of Escherichia coli for gram scale production of the antitumor drug deoxyviolacein from glycerol. Biotechnol. Bioeng. 111, 2280-2289 (2014).
32. Cress, B. F., Erkert, K. A., Barquera, B. & Koffas, M. A. G. Draft Genome Sequence of Pseudoalteromonas luteoviolacea Strain B (ATCC 29581). Genome Announc. 1, e0004813 (2013).
33. Shen, C. R. et al. Driving forces enable high-titer anaerobic 1-butanol synthesis in Escherichia coli. Appl. Environ. Microbiol. 77, 2905-15 (2011).
34. Cirino, P. C., Chin, J. W. & Ingram, L. O. Engineering Escherichia coli for xylitol production from glucose-xylose mixtures. Biotechnol. Bioeng. 95, 1167-76 (2006).
35. Neidhardt, F. C., Bloch, P. L. & Smith, D. F. Culture Medium for Enterobacteria. J. Bacteriol. 119, 736-747 (1974).
36. Temme, K., Hill, R., Segall-Shapiro, T. H., Moser, F. & Voigt, C. A. Modular control of multiple pathways using engineered orthogonal T7 polymerases. Nucleic Acids Res. 40, 8773-81 (2012).
37. Rodrigues, A. L. et al. Microbial production of the drugs violacein and deoxyviolacein: analytical development and strain comparison. Biotechnol. Lett. 34, 717-20 (2012).